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Engineering, and §Bindley Bioscience Center, Purdue University, West Lafayette, IndianaABSTRACT It is thought that the pathological cascade in Alzheimer’s disease is initiated by the formation of amyloid-b (Ab)
peptide complexes on cell membranes. However, there is considerable debate about the nature of these complexes and the
type of solution-phase Ab aggregates that may contribute to their formation. Also, it is yet to be shown that Ab attaches strongly
to living cell membranes, and that this can happen at low, physiologically relevant Ab concentrations. Here, we simultaneously
measure the aggregate size and fluorescence lifetime of fluorescently labeled Ab1-40 on and above the membrane of cultured
PC12 cells at near-physiological concentrations. We find that at 350 nM Ab concentration, large (>>10 nm average hydrody-
namic radius) assemblies of codiffusing, membrane-attached Ab molecules appear on the cell membrane together with a near-
monomeric species. When the extracellular concentration is 150 nM, the membrane contains only the smaller species, but with
a similar degree of attachment. At both concentrations, the extracellular solution contains only small (~2.3 nm average hydro-
dynamic radius) Ab oligomers or monomers. We conclude that at near-physiological concentrations only the small oligomeric Ab
species are relevant, they are capable of attaching to the cell membrane, and they assemble in situ to form much larger
complexes.INTRODUCTIONAbnormal aggregation of misfolded proteins and their depo-
sition in the brain are common molecular features of many
neurodegenerative diseases, including Alzheimer’s and Par-
kinson’s diseases (1,2). A hallmark of Alzheimer’s disease
is the extracellular aggregation of amyloid-b (Ab) protein
into insoluble b-sheet-rich amyloid fibrils (1,3). Conse-
quently, considerable efforts have been made to understand
the aggregation of this peptide in solution (4,5). However,
major unresolved questions remain regarding the molecular
mechanism underlying Ab toxicity, including the nature
of the interaction of the Ab with living cell membranes,
the type of Ab aggregates that take part in this interaction,
and the size of structures they form on the membrane.
Also, although Ab aggregation is a hallmark of the disease,
Ab does not appear to form any large aggregates in vitro at
concentrations that are supposed to exist in vivo.
Because Ab is an extracellular protein that is produced
by proteolytic processing of the membrane-bound amy-
loid precursor protein (6), interaction with the membrane
appears to be an obligatory initial step in the pathway to
toxicity (7). A dominant hypothesis for toxicity is that Ab
molecules assemble into ion-permeable structures on the
cell membrane. There is considerable evidence for the for-
mation of ion-channel-like Ab structures on the cell mem-
brane (8,9). Atomic force microscopy imaging has shown
~16 nm large channel-like structures in artificial membranes
incubated with Ab (10,11). Separate electrophysiologicalSubmitted March 31, 2010, and accepted for publication July 9, 2010.
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increase their Ca2þ ion conductivity in the presence of Ab
aggregates, supporting the channel hypothesis (12,13).
Molecular modeling results suggest that Ab molecules can
assemble into a small (<5 nm diameter) membrane-span-
ning, ion-conducting pore (14). On the other hand, other
studies indicate that Ab associates with the plasma mem-
brane outer leaflet and forms nonspecific structures, leading
to membrane thinning and deformation (15,16). Binding
studies using surface plasmon resonance and fluorescence
anisotropy suggest that Ab binds to membrane lipids (17).
However, to date there is no direct proof of the formation
of any type of Ab assemblies on living cell membranes.
Another major issue is the identity of the Ab aggregate
that gives rise to the putative membrane structures. In the
aqueous phase, Ab aggregation into the final fibrillar form
occurs via several concentration-dependent steps (18,19),
and many of the intermediate species are quasi-stable
(20). It is now believed that one or more of the soluble inter-
mediates (species ranging from small soluble oligomers to
the larger protofibrils), rather than the mature fibrils, are
key to the interaction with the cell membrane (21–24).
Zn2þ reduces the population of these soluble Ab aggregates
in solution (22) and it also inhibits the Ab induced Ca2þ
currents and toxicity (9,13), suggesting a link between these
soluble aggregates and membrane assemblies. However,
other experiments have pointed to different types of soluble
aggregates as the key bioactive species. Some studies have
shown that Ab can aggregate in solution into structures
that appear to have an annular morphology similar to that
of membrane ion channels (14). It is has been hypothesizeddoi: 10.1016/j.bpj.2010.07.020
1970 Nag et al.that these annular structures, formed in the solution phase
(25–27), somehow incorporate into the membranes and
function as unregulated ion channels, although the thermo-
dynamics of membrane insertion for a structure formed in
a hydrophilic environment remains unclear. Some authors
have suggested that spherical amyloid aggregates (ranging
from 5 nm (27) to 20 nm (28) in diameter) are the most bio-
active, and very small oligomers (near-monomeric species)
are unable to interact with the membrane (29). A competing
hypothesis is that very small oligomers (especially dimers)
are bioactive, and a dimer-rich solution of Ab strongly
affects the long-term potentiation of synaptic connections
(30,31). Other findings suggest that octamers or similar
species may be the basic units that interact with the cell
membrane (11). It is possible that these small oligomers
initially associate with the membrane as separate entities
and then assemble in situ to form larger Ab assemblies
that compromise the cell membrane permeability (11).
Some studies suggest that 56 kD oligomers may be the
most toxic species (32), and also there is some evidence
that larger structures (‘‘protofibrils’’ ranging in size from
tens to hundreds of nanometers) are responsible for neuronal
death (33). An alternative hypothesis states that Ab enters
the cytoplasm of the neuronal cells and interacts with
some vital cellular processes, such as neurotransmitter pack-
aging (34). Even for this hypothesis, Ab must first interact
with the membrane in a way that facilitates its passage
through the membrane. At present, it is fair to say that
a multitude of possibilities exist, and no measurement has
directly and unambiguously linked any particular type of
solution phase aggregate with the formation of the mem-
brane assemblies.
The lack of experimental evidence is due to the demand-
ing requirements of sensitivity, size-resolution, and biocom-
patibility of the candidate technique. Ab concentrations in
the cerebrospinal fluid in the brain of Alzheimer’s patients
are much less than 1 mM (35,36). Electrophysiological mea-
surements have also established the disruptive effect of
such low concentrations of Ab on neuronal communication
(30,37,38). However, most aggregation measurements are
carried out at concentrations of many micromolar because
techniques employed to measure protein aggregation, such
as dynamic light scattering, thio-T binding, and size-exclu-
sion chromatography are typically not sensitive to nanomo-
lar-level protein concentrations and are applicable only in
the solution phase. Such high concentrations may allow
the formation of large aggregates that may not be relevant
at lower physiological concentrations.
A few studies have probed the presence of Ab aggregates
on living cells, mainly using fluorescence-based techniques
that are sensitive and biocompatible. Fluorescence imaging
studies have shown that Ab colocalizes with neurons and
neuronal processes (39), but these studies did not show
whether they physically attach to the membranes. A recent
pioneer study of fluorescent Ab (at 2 mM concentration)Biophysical Journal 99(6) 1969–1975using confocal imaging and photobleaching suggested that
Ab associates with PC12 cell membranes, and a fraction
of these Ab molecules are within the Forster radii (i.e.,
a few nanometers) of each other (40). This raises several
important questions: Do the observed Ab patches represent
true membrane aggregates? Can these aggregates form at
near-physiological concentrations? How large are these
aggregates? Do these aggregates represent the incorporation
of similar-sized aggregates that are preformed in the solu-
tion? If not, what type of solution aggregates correlate
with the formation of the membrane aggregates? Here, we
explore these questions by studying the aggregation of Ab
at submicromolar concentrations on the cell membrane of
living PC12 cells, as well as in the extracellular medium
close to the cell membranes. PC12 cells are mammalian in
origin, have been used as neuronal mimics, are easily
cultured, and have been used in the past to study the effects
of Ab on living cells (40,41). Our use of these cells allows us
to directly compare our results with those of previous
studies.
We use confocal fluorescence imaging to locate the fluo-
rescently labeled Ab on the cell membrane and in the extra-
cellular space. We then measure the diffusion constant
(which is related to the size) of Ab monomers and aggre-
gates using fluorescence correlation spectroscopy (FCS)
(42–44). This technique has been shown to be effective
for studying Ab aggregation in the solution phase at nano-
molar concentrations (45) and is biocompatible (46,47).
We simultaneously determine the fluorescence lifetime
with time-correlated single photon counting (TCSPC) to
verify the attachment of Ab with the cell membrane. These
experiments are repeated at two different concentrations to
determine whether the observed characteristics are concen-
tration-dependent.MATERIALS AND METHODS
Materials
Purified synthetic Ab1-40 and fluorescein-labeled Ab1-40 (labeled at the
N-terminus through a lysine, Fl-Lys-Ab1-40) was purchased from rPeptide
(San Jose, CA). The labeled and unlabeled peptide was used in a ratio of
1:1 without further purification. Buffer salts were purchased from Sigma
(St. Louis, MO). The peptide was made in artificial cerebrospinal fluid
buffer (146 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4,
0.4 mM KH2PO4, 5 mM dextrose, and 20 mM Na2HPO4, pH adjusted to
7.35). All experiments were performed at 25C.Cell culture
PC12 cell lines were maintained in Dulbecco’s modified Eagle’s medium
(high glucose; ATCC, Manassas, VA) containing 10% horse serum (Sigma)
and 5% fetal bovine serum (Sigma), and then placed in cell culture dishes
precoated with 1 mg/mL poly-L-lysine (Sigma). Cells were maintained in
an incubator at 37C with 5% CO2. For living-cell microscopy studies,
cells were seeded onto sterilized No. 1 coverslip (VWR International,
Batavia, IL) and placed inside a six-well plate.
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Measurements were performed with a confocal microscope setup with
TCSPC and FCS facility (Time Harp200; PicoQuant GmbH, Berlin,
Germany). The system uses a stage scanning confocal setup on an inverted
microscope (Olympus IX71, Olympus America Inc., Centre Valley, PA),
with two picosecond pulsed diode lasers (467 nm excitation; PicoQuant,
GmbH Berlin, Germany). The excitation power and frequencies of the
lasers were optimized to avoid photobleaching of the fluorophores. The
laser powers used in the experiments were 30 mW and 40 mW at 467 nm
and 636 nm excitation, respectively, with a pulse frequency of 40 MHz
for both lasers. The laser beams were focused in the sample volume using
an apochromatic 60X water immersion objective (Olympus America Inc.)
with an NA of 1.2, and the emitted fluorescence was collected using the
same objective and separated from the excitation beam by a dichroic mirror.
A 50 mm pinhole was used to reject the out-of-focus fluorescence. The over-
all fluorescence collected was separated using a dichroic cube beam splitter
and filtered by a suitable emission filter before it was detected by two single
photon avalanche photodiodes (SPCM-AQR; PerkinElmer, Waltham, MA).
The fluorescence lifetime was measured using the TCSPC module in time-
tagged time-resolved mode. Analyses of the fluorescence lifetime signals
were performed with Origin 7.0 Software (Origin Labs, Northampton,
MA). An in-house-developed analysis algorithm (45), termed MEMFCS
(maximum entropy method-based analysis of FCS data), was used to eval-
uate the diffusion time distribution.1RESULTS
Fluorescence imaging suggests that Ab
associates with cell membranes
We investigated the association of fluorescently labeled
extracellular Ab with the cell membranes using confocal
imaging. We incubated separate sets of PC12 cells with
a buffer containing 150 nM and 350 nM fluorescein-labeled
Ab, respectively, for 15 min and imaged the cells with
a confocal microscope. Confocal images of the cell mem-
branes show multiple bright patches (Fig. 1 a, arrows),
which are in general brighter than the structures observed
from cells that were not incubated with fluorescein-labeled
Ab (Fig. 1 b). Images obtained from the cells incubated
with the 150 nM solution are similar to those obtained
from the 350 nM solution (data not shown). Diffuse bright-FIGURE 1 Fluorescence images of labeled Ab on cell membranes. (a)
Representative confocal fluorescence image of a PC12 cell recorded after
the addition of 350 nM of fluorescein-labeled Ab1-40. White arrows show
the attachment of Ab to the membrane. (b) Autofluorescence image from
a PC12 cell before Ab addition.ness is seen near the top and bottom optical sections of
the cells, whereas the intermediate sections show a rim-
like annular appearance (Fig. 1 b, rightmost cell). These
are characteristics of a cell membrane in a confocal image.
The appearance of bright patches suggests that Ab aggre-
gates on the membrane, but the optical resolution of
confocal microscopy (~750 nm in the longitudinal and
~300 nm in the lateral direction) was not sufficient to estab-
lish a molecular-level attachment with the membrane, nor
could it provide evidence of a molecular-level association
between different Ab monomers.Fluorescence lifetime data show membrane
attachment
Fluorescence lifetimes were measured from the bright mem-
brane-associated patches visible in the confocal images.
Lifetime data were obtained from the same confocal image
data set (the photon intensity information is used to calcu-
late the confocal image, and the photon arrival information
is used to calculate the lifetime and the fluorescence
correlation curves). The lifetime of 150 nM Ab recorded
in the solution ~10 mm above the cell membrane fits well
for a single component with a lifetime of 3.9 5 0.1 ns
(Fig. 2, squares). However, the data from the cell mem-
brane (for 150 nM extracellular Ab) fits well only when a
minimum of two components are used (1.3 5 0.4 and
4.1 5 0.2 ns at a 1:1.9 amplitude ratio; Fig. 2, circles).
The lifetime data obtained from the membrane exposed to
150 nM extracellular Ab (Fig. 2, circles) is similar to those
exposed to the 350 nM solution (see Fig. S1 in the Support-
ing Material). The long lifetime component is similar to that
obtained from the solution. The faster decay component-2 0 2 4 6 8 10 12 14
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FIGURE 2 Fluorescence lifetime of Ab on cell membranes. TCSPC data
of the fluorescence lifetime of 150 nM Ab obtained from the extracellular
solution (square) and the cell membrane (circle), with their corresponding
single exponential and two exponential fits, respectively (solid line).
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FIGURE 3 Fluorescence autocorrelation of Ab
on cell membranes. (a) Fluorescence autocorrela-
tion traces obtained from the extracellular solution
containing 150 nM Ab (circles) and 350 nM Ab
(triangles). (b) Corresponding diffusion-time distri-
butions obtained by fitting the data with the
MEMFCS algorithm. (c) Fluorescence autocorrela-
tion curves obtained from the cell membrane for
150 nM Ab (circle) and 350 nM (triangles) Ab
concentrations. (d) Diffusion-time distribution
obtained from fitting the data in c.
1972 Nag et al.indicates that the fluorescence of a part of the population is
quenched. Separate evidence of this quenching can be found
from a photon counting histogram (PCH) analysis of the
same set of data reported in Fig. S2. The PCH data binned
at 10 ms show that the peak emission rate of the particles
shifts from a value of 18,700 photons per second (in the
extracellular medium) to 5400 photons per second (on
the membrane). A decrease in the fluorescence counts and
the lifetime indicates dynamic quenching in the system.
Together, these data show that a fraction of the Ab mole-
cules are in an environment different from those in the
solution.FCS shows membrane Ab aggregates
Next, we investigate whether these Ab molecules associate
with each other to form intermolecular complexes on the
membrane. Multiple molecules codiffusing as a single
particle would be a clear evidence of a molecular-level asso-
ciation. Because FCS analyzes the translational diffusion of
a particle, it can provide information about such an associ-
ation, as well as measure the diffusion constant (which is
a measure of the size) of the complexes. The same data
set obtained for imaging and lifetime determination also
contains time-stamped data appropriate for FCS analysis.
We separately analyze the FCS data obtained from the solu-
tion above the membrane (Fig. 3 a), as well as from the
membrane itself (Fig. 3 c), for both the Ab concentrationsBiophysical Journal 99(6) 1969–1975(150 nM and 350 nM). The FCS data are fitted with the
MEMFCS fitting routine, which gives a model-free analysis
of underlying diffusion times (45). Although distribution of
diffusion constants obtained from MEMFCS can be (and
usually is) wider than the actual distribution, the absence
of a particular diffusion constant in this analysis is a reliable
indicator of the absence of that species. The distributions
obtained from the solution phases of the two different
concentrations are similar, with the peak of the distribution
at 126 ms in both (Fig. 3 b). The 1/e2 point of the distribution
extends to 281 ms and 355 ms for the 350 nM and 150 nM
solutions, respectively. The 150 nM data have somewhat
larger errors, and consequently the distribution is slightly
wider. However, the relative amplitudes of the smaller com-
ponents are consistently higher in the low-concentration
solution. The diffusion constants are calculated from the
diffusion time with the help of a calibrant (in this case
with free fluorescein dye in solution, which has a known
diffusion constant of 4.25  106cm2s1 and a hydrody-
namic radius of 0.57 nm (48)). In our setup, fluorescein
has a measured diffusion time of 32 ms under identical
conditions. This calibration yields a diffusion constant of
1.1  106cm2s1 (or a hydrodynamic radius of 2.3 nm)
for the peak of the size distribution in the solution above
the membrane. The analysis of the membrane data (Fig. 3 c,
circles) obtained from the 150 nM Ab solution shows
a distribution with a single peak at 200 ms (D ¼ 6.8 
107cm2s1; Fig. 3 d, circles). The diffusion times in the
Amyloid-b Complexes on Membranes 1973membrane are expected to be larger due to the viscous
environment, as well as the molecule-specific interactions
and crowding. To obtain an estimate of this environmental
factor, we performed FCS measurements of Alexa Fluor
680-labeled wheat germ agglutinin (WGA, a membrane
protein) on PC12 cell membranes and in the extracellular
solution. This measurement shows that for this molecule,
the ratio of the diffusion time in the aqueous solution to
that in the membrane is ~5.5 (Fig. S3). Hence, the Ab on
the cell membrane may be expected to have a typical diffu-
sion time of ~700 ms, which is larger than the observed
value. This aspect is discussed later in more detail.
In contrast, when cells are incubated with the 350 nM Ab
solution, the size distribution in the membrane (Fig. 3 c,
triangles) shows two distinct Ab-bound complexes charac-
terized by a typical diffusion time of 200 ms (D z 6.8 
107cm2s1) and 50 ms (or larger), respectively (D% 2.7
109cm2s1, Fig. 3 d, triangles). The individual peak posi-
tions vary considerably (a representation of this variation
across 10 different measurements performed on three dif-
ferent days is presented in Fig. S4). However, the robust
feature of all of these measurements is the presence of a
secondary peak at large diffusion times (representing large
aggregates) in addition to the main peak at smaller diffusion
times. The secondary peak clearly signifies the presence of
assemblies much larger than those observed in the solution.DISCUSSION
The association of extracellular Ab aggregates with the cell
membrane is likely to be a key step in the pathology of Alz-
heimer’s disease. Fig. 1 shows that fluorescein-labeled Ab
preferentially localizes on the cell membrane of the PC12
cells. Such an association has been observed before, but
only at much higher concentrations of extracellular Ab
(40). Our data show that this association takes place even
at 150 nM and 350 nM Ab concentrations, which is far
below the solubility (i.e., precipitation) limit of Ab in
aqueous solutions (19). The FCS data obtained from the
extracellular solution show that Ab aggregates into struc-
tures with a typical radius of 2.3 nm, and particles much
larger than this are absent (the 1/e2 point of the peak of
the hydrodynamic radius distribution is at 6.3 nm) at these
concentrations. We note that a fluorescent label is required
for our single-molecule-level experiments performed with
a cellular background, and all the conclusions drawn are
strictly valid only for this labeled molecule.
Given the relatively poor resolution of the confocal
microscope (~250 nm in the radial and 700 nm in the axial
direction) this membrane localization may not imply a true
‘‘attachment’’ of Ab with the cell membrane. The fluores-
cence lifetime data help us clarify this point further. The
fluorescence lifetimes of most fluorophores are sensitive to
the chemical nature of the environment. In our experiments,
the fluorescein label is placed on the N-terminal end of Ab,which is supposed to be unstructured and therefore exposed
to the environment even in the aggregated state. Indeed, the
lifetime of fluorescein in the aqueous solution (3.8 ns; data
not shown) is not very different from that of the fluorescein-
Ab conjugate (4.1 ns). We expect a change in the lifetime
of this fluorescein molecule if this end experiences the
nonaqueous environment of the membrane. This is indeed
manifested in the second, faster component that emerges
when we analyze the lifetime data from the optical sections
containing the cell membrane. The reduction in the mean
lifetime (tm¼ 3.4 ns vs. tm ¼ 4.1 ns in the extracellular
medium) is also reflected in a net change of the brightness
of the fluorescein fluorophores. An analysis of the data
with a PCH technique (49) shows a concomitant reduction
of the peak photon emission rate per particle (Fig. S2). Life-
time data obtained from both 150 nM and 350 nM Ab solu-
tions also show a very similar change (Fig. S1) in the
lifetime (the second component is at 1.3 ns), indicating
that the molecular details of membrane association are
similar. We note here that aggregation of Ab in the solution
does not significantly change the lifetime of the fluorescein
label, as observed in separate in vitro experiments (Fig. S5).
Moreover, membrane attachment is expected to slow down
the diffusion of the molecules due to the inherently higher
viscosity of the membrane. This slowing down is also
observed (compare Fig. 3 b, circles, and Fig. 3 d, circles).
Our observations therefore signify a strong attachment,
and possible outright incorporation, of Ab molecules into
the cell membrane. This attachment occurs at least down
to 150 nM of Ab concentration. We note that some degree of
nonspecific adsorption of a hydrophobic molecule such as
Ab can be expected on different surfaces. However, mem-
brane lifetime data and diffusion measurements bolster the
conclusion that Ab binds strongly to natural cell membranes
at very low concentrations.
We now consider whether such an association leads to the
formation of large Ab complexes on the membrane. To
make an inference about particle size from an analysis of
diffusion constants, we need to account for the viscosity
of the environment. We experimentally estimate this factor
by measuring the diffusion of the WGA molecule in the
cell membrane. The WGA protein is known to incorporate
into the membrane, and as mentioned above, its diffusion
time slows down by a factor of 5.5 in these cells (Fig. S3).
FCS measurements show that for the 150 nM Ab solution,
structures in the membrane diffuse only 2.5 times more
slowly than in the solution. The diffusion constant of mono-
meric Ab in aqueous solution is ~2.8 106cm2s1 (S. Nag
and S. Maiti, unpublished), which in the membrane would
have a diffusion time close to the observed value. It is
likely that membrane-incorporated Ab at this concentration
is monomeric (or at best it consists of small oligomers).
However, we note that because the optical probe volume
extends into the space above the cell membrane, a short
diffusion time may also arise from the contribution of theBiophysical Journal 99(6) 1969–1975
1974 Nag et al.monomeric population of the unbound Ab in solution. How-
ever, the fluorescence signal levels from the probe volumes
that do and do not contain the membrane show that the con-
tribution of the membrane-bound Ab should dominate these
measurements. An alternative possibility is that the binding/
unbinding kinetics of Ab to the cell membrane shortens the
apparent diffusion time. In any case, the membrane-attached
structures are at least no larger than the structures observed
in the extracellular medium. We therefore conclude that
at a 150 nM Ab concentration, the small extracellular Ab
structures do incorporate into the membrane (even if tran-
siently), but they do not aggregate further.
At a 350 nM Ab concentration, the cell membrane shows
an additional species with a diffusion constant of <2.7 
109cm2s1. This diffusion time cannot be unambiguously
translated into a physical size for the aggregates in a model-
free manner. However, the Stokes-Einstein model (D~1/r)
presents a lower limit for the size of these structures, and
much higher sizes are predicted by the Saffman-Delbruck
model (50). We note that such Stokes-Einstein behavior,
which assumes a spherical shape, has been experimentally
observed for protein molecules diffusing on the cell mem-
brane (51). Thus, our results would suggest that structures of
the order of 200 times that of the monomers (i.e., >150 nm)
form at this extracellular Ab concentration. It is also quite
likely that such large Ab aggregates do not freely diffuse
on the membrane and hence the actual size is smaller than
this apparent size, but still it is obvious that these are rather
large objects (>>10 nm).
This large complex formation happens at a concentration
that is much less than the solubility limit of Ab in the extra-
cellular medium (18), and therefore such objects are not
thermodynamically stable in the solution phase. Their
formation in the membrane is most likely a manifestation
of the lower free energy of association needed for particles
to aggregate on a two-dimensional surface compared to
a three-dimensional surface. Our data do not distinguish
between strong attachments with the membrane versus an
actual incorporation. However, the strong effect on the life-
time suggests that the Abmolecules most likely do incorpo-
rate into the membrane. It appears that solution phase
particles with radii ~2–3 nm are sufficient for the formation
of the large assemblies in the membrane. The observed size
excludes most of the protofibrillar (24) or amylospheroid
structures (28), which have been found to form at larger
concentrations in the aqueous solution and have been
hypothesized to play a role in forming aggregates on the
membrane. Though the size distribution peaks at 2.3 nm
for both the 150 nM and 350 nM solutions, the relative
concentration of the small species (e.g., monomers) is
higher at 150 nM (Fig. 3 b), as can be expected for near-
equilibrium solutions. This implies that the main difference
between the two is the absolute concentration of the 2.3 nm
species. These small oligomers are therefore likely to be the
key for membrane complex formation.Biophysical Journal 99(6) 1969–1975In conclusion, our results provide a direct observation of
the formation of large Ab complexes on living cell mem-
branes at near-physiological concentrations. Their forma-
tion critically depends on the extracellular concentration
of Ab in this range. We show that these membrane com-
plexes result from the incorporation and in situ assembly
of small (~2–3 nm hydrodynamic radius) Ab particles
present in the extracellular medium.SUPPORTING MATERIAL
Fivefigures are available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(10)00890-8.
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